APO-COLESEVELAM DIN 02494051
Health Canada record
| Active ingredient(s) | COLESEVELAM HYDROCHLORIDE 625 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | C10AC04 COLESEVELAM |
| Original market date | 23-Jul-2020 |
| Current status date | 23-Jul-2020 |
| Source | Health Canada DPD |
Establishment licence of the holder
Apotex Inc — licence 100375, currently licensed, last inspection rating C (2026-04-21).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing COLESEVELAM HYDROCHLORIDE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02566869 | JAMP COLESEVELAM | JAMP PHARMA CORPORATION | Tablet | COLESEVELAM HYDROCHLORIDE 625 MG | Approved |
| 02373955 | LODALIS | BAUSCH HEALTH, CANADA INC. | Tablet | COLESEVELAM HYDROCHLORIDE 625 MG | Marketed |
| 02432463 | LODALIS | BAUSCH HEALTH, CANADA INC. | Powder For Suspension | COLESEVELAM HYDROCHLORIDE 3.75 G | Dormant |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 22895 | 2019-11-12 | Abbreviated New Drug Submission (ANDS) |
International API supply for COLESEVELAM HYDROCHLORIDE
8 active FDA Drug Master Files.
Request a quote for APO-COLESEVELAM